Stocks and Investing Stocks and Investing
Tue, June 23, 2020
Mon, June 22, 2020

Brian Abrahams Maintained (BIIB) at Hold with Decreased Target to $273 on, Jun 22nd, 2020


Published on 2024-10-27 08:26:35 - WOPRAI, Brian Abrahams
  Print publication without navigation


Brian Abrahams of RBC Capital, Maintained "Biogen Inc." (BIIB) at Hold with Decreased Target from $303 to $273 on, Jun 22nd, 2020.

Brian has made no other calls on BIIB in the last 4 months.



There are 10 other peers that have a rating on BIIB. Out of the 10 peers that are also analyzing BIIB, 4 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Aaron Gal of "Bernstein" Downgraded from Buy to Hold and Decreased Target to $297 on, Tuesday, June 9th, 2020
  • Alethia Young of "Cantor Fitzgerald" Reiterated at Hold with Decreased Target to $308 on, Friday, May 1st, 2020
  • Evan Seigerman of "Credit Suisse" Maintained at Hold with Decreased Target to $310 on, Thursday, April 23rd, 2020
  • Salim Syed of "Mizuho" Maintained at Hold with Increased Target to $316 on, Tuesday, February 25th, 2020


These are the ratings of the 6 analyists that currently disagree with Brian


  • Brian Skorney of "Baird" Maintained at Sell with Decreased Target to $228 on, Friday, June 19th, 2020
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $350 on, Friday, April 24th, 2020
  • Steven Seedhouse of "Citigroup" Downgraded from Hold to Strong Sell on, Thursday, April 23rd, 2020
  • Jay Olson of "Oppenheimer" Maintained at Buy with Decreased Target to $365 on, Thursday, April 23rd, 2020
  • Matthew Harrison of "Morgan Stanley" Maintained at Sell with Decreased Target to $301 on, Thursday, April 23rd, 2020
  • Robyn Karnauskas of "SunTrust Robinson Humphrey" Maintained at Strong Buy with Decreased Target to $330 on, Thursday, April 23rd, 2020
Contributing Sources